Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Liabilities: 2017-2024

Historic Other Non-Current Liabilities for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to $894,000.

  • Organogenesis Holdings' Other Non-Current Liabilities rose 93.89% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 93.89%. This contributed to the annual value of $894,000 for FY2024, which is 26.30% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Other Non-Current Liabilities of $894,000 as of FY2024, which was down 26.30% from $1.2 million recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Other Non-Current Liabilities ranged from a high of $8.0 million in FY2020 and a low of $894,000 during FY2024.
  • For the 3-year period, Organogenesis Holdings' Other Non-Current Liabilities averaged around $1.1 million, with its median value being $1.1 million (2022).
  • In the last 5 years, Organogenesis Holdings' Other Non-Current Liabilities grew by 19.88% in 2020 and then tumbled by 80.47% in 2021.
  • Organogenesis Holdings' Other Non-Current Liabilities (MRY) stood at $8.0 million in 2020, then plummeted by 80.47% to $1.6 million in 2021, then dropped by 27.94% to $1.1 million in 2022, then increased by 8.11% to $1.2 million in 2023, then decreased by 26.30% to $894,000 in 2024.
  • Its Other Non-Current Liabilities stands at $894,000 for FY2024, versus $1.2 million for FY2023 and $1.1 million for FY2022.